Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Alba Rodriguez Meira and Ioannis Akoumianakis for winning this year's RDM graduate prize.

Sheldonian theatre photo

Find out more about our award winners:

PhotoAlba Rodriguez-Meira completed her DPhil under the supervision of Professors Adam Mead and Sten Eirik Jacobsen at the Molecular Haematology Unit (WIMM), where she characterized the genetic and molecular heterogeneity of leukemic stem cells, which give rise to blood cancer. Alba pioneered the development of a new single-cell sequencing method that correlates mutations, cell surface proteomics and whole transcriptome analysis from the same cell (TARGET-seq).

This uniquely allowed her to resolve the molecular signatures of genetically-distinct leukaemic stem cells in patients with myelofibrosis. Ultimately, this led to the identification of therapeutic vulnerabilities specifically affecting mutant cells, which could help develop better therapeutic strategies for patients with blood cancer. The technique has been widely adopted in many laboratories in the world, and has resulted in many collaborations both at the MRC WIMM and internationally. In addition to her academic work, Alba is also an active member of Spanish Researchers in the UK, where she organizes scientific and outreach events, and a member of the International Society of Experimental Hematology Publications Committee. Find out more about her work

Portrait photoIoannis Akoumianakis's keen interest in cardiovascular research was expressed early on during his training as a medical student at the University of Crete, Greece. In 2014, after completing his medical studies, he came to Oxford to read for a DPhil in Cardiovascular Medicine under the supervision of Professors Charalambos Antoniades and Keith Channon, exploring the crosstalk between metabolism and vascular disease.

Ioannis' research was also the first to characterise the consequences of vascular insulin signalling in humans with atherosclerosis, where he found that insulin had a detrimental, Janus-like effect on the vascular wall, which was determined by the presence of vascular insulin resistance, and it was reversed by dipeptidyl peptidase 4 inhibitors, a class of drugs commonly used in the treatment of diabetes. Find out more about his work

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with


Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.